Related Experiment Videos
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
D Cappellen1, C De Oliveira, D Ricol
1Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.
Nature Genetics
|September 2, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Dynapenic Abdominal Obesity as a Risk Factor for Metabolic Syndrome in Individual 50 Years of Age or Older: English Longitudinal Study of Ageing.
The journal of nutrition, health & aging·2023
Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9.
Nature communications·2023
Multiple Level Effects of Imazethapyr on Leptodactylus latinasus (Anura) Adult Frogs.
Archives of environmental contamination and toxicology·2021
The expanding role of Cav3 channels in glioblastoma.
Trends in pharmacological sciences·2026
Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis.
International urology and nephrology·2026
Interaction of circular RNAs with splicing factors in cervical cancer: Modulation, interplay and theranostics (Review).
Molecular medicine reports·2026
Margin-enriched CD4+ central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma.
International journal of biological sciences·2026